| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-15 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.35 | 3e-15 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-15 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-14 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.32 | 5e-14 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.32 | 5e-14 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-14 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.34 | 2e-13 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-11 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-11 |